 |
Play Video: The Importance of Insider Buying
|
|
 |
The table below summarizes the most recent SBPH insider buying information, with links below the price to see the
CAGR achieved by each insider on their purchases. As the saying goes on Wall St., there are many
possible reasons to sell a stock, but only one reason to buy. Watch the importance of insider buying video for more
information about why SBPH insider buys are important for investors to follow.
| Date | Insider | Price | Amount |
11-14-2019 Insider Buy |
Jonathan Freve CFO & Treasurer |
$3.04
CAGR »
|
$15,200.00 5,000 shares |
11-13-2019 Insider Buy |
Martin J. Driscoll President and CEO |
$2.83
CAGR »
|
$14,150.00 5,000 shares |
6-28-2019 Insider Buy |
Scott Andrew Smith Director |
$4.09
CAGR »
|
$49,080.00 12,000 shares |
5-29-2019 Insider Buy |
Martin J. Driscoll President and CEO |
$6.03
CAGR »
|
$60,300.00 10,000 shares |
5-29-2019 Insider Buy |
Jonathan Freve CFO & Treasurer |
$5.40
CAGR »
|
$27,000.00 5,000 shares |
5-21-2019 Insider Buy |
Martin J. Driscoll President and CEO |
$6.63
CAGR »
|
$33,150.00 5,000 shares |
4-30-2019 Insider Buy |
Martin J. Driscoll President and CEO |
$7.33
CAGR »
|
$73,350.00 10,000 shares |
8-13-2018 Insider Buy |
Martin J. Driscoll President and CEO |
$12.02
CAGR »
|
$48,080.00 4,000 shares |
2-28-2018 Insider Buy |
Martin J. Driscoll President and CEO |
$12.83
CAGR »
|
$12,830.00 1,000 shares |
9-14-2017 Insider Buy |
Martin J. Driscoll President and CEO |
$14.84
CAGR »
|
$14,840.00 1,000 shares |
8-4-2017 Insider Buy |
David Arkowitz Director |
$12.24
CAGR »
|
$30,602.00 2,500 shares |
8-3-2017 Insider Buy |
Martin J. Driscoll President and CEO |
$12.36
CAGR »
|
$24,710.00 2,000 shares |
6-27-2017 Insider Buy |
Kurt M. Eichler Director |
$13.00
CAGR »
|
$999,999.00 76,923 shares |
3-7-2017 Insider Buy |
Martin J. Driscoll President and CEO |
$9.44
CAGR »
|
$18,880.00 2,000 shares |
2-23-2017 Insider Buy |
Kurt M. Eichler Director |
$8.76
CAGR »
|
$10,515.60 1,200 shares |
12-15-2016 Insider Buy |
Martin J. Driscoll President and CEO |
$8.50
CAGR »
|
$17,000.00 2,000 shares |
11-30-2016 Insider Buy |
Martin J. Driscoll President and CEO |
$7.98
CAGR »
|
$15,960.00 2,000 shares |
11-9-2016 Insider Buy |
Martin J. Driscoll President and CEO |
$8.84
CAGR »
|
$17,680.00 2,000 shares |
11-9-2016 Insider Buy |
Kurt M. Eichler Director |
$8.69
CAGR »
|
$60,830.00 7,000 shares |
9-13-2016 Insider Buy |
Kurt M. Eichler Director |
$12.50
CAGR »
|
$6,125.00 490 shares |
9-9-2016 Insider Buy |
Nezam H. Afdhal Chief Medical Officer |
$12.50
CAGR »
|
$30,000.00 2,400 shares |
9-2-2016 Insider Buy |
Martin J. Driscoll President and CEO |
$11.75
CAGR »
|
$11,750.00 1,000 shares |
8-30-2016 Insider Buy |
Martin J. Driscoll President and CEO |
$12.41
CAGR »
|
$12,410.00 1,000 shares |
8-23-2016 Insider Buy |
Kurt M. Eichler Director |
$10.73
CAGR »
|
$32,190.00 3,000 shares |
8-24-2016 Insider Buy |
Nezam H. Afdhal Chief Medical Officer |
$11.92
CAGR »
|
$23,844.00 2,000 shares |
8-23-2016 Insider Buy |
Jonathan Freve CFO, Treasurer & Secretary |
$10.74
CAGR »
|
$10,740.00 1,000 shares |
8-22-2016 Insider Buy |
Martin J. Driscoll President and CEO |
$11.43
CAGR »
|
$22,860.00 2,000 shares |
8-12-2016 Insider Buy |
Nezam H. Afdhal Chief Medical Officer |
$11.01
CAGR »
|
$28,618.40 2,600 shares |
8-16-2016 Insider Buy |
Martin J. Driscoll President and CEO |
$11.29
CAGR »
|
$22,570.00 2,000 shares |
8-12-2016 Insider Buy |
Nezam H. Afdhal Chief Medical Officer |
$11.33
CAGR »
|
$29,449.68 2,600 shares |
8-9-2016 Insider Buy |
Martin J. Driscoll President and CEO |
$11.03
CAGR »
|
$22,050.00 2,000 shares |
8-4-2016 Insider Buy |
Martin J. Driscoll President and CEO |
$9.96
CAGR »
|
$19,920.00 2,000 shares |
8-4-2016 Insider Buy |
Jonathan Freve CFO, Treasurer & Secretary |
$9.75
CAGR »
|
$9,750.00 1,000 shares |
8-4-2016 Insider Buy |
Kurt M. Eichler Director |
$9.79
CAGR »
|
$9,790.00 1,000 shares |
5-11-2016 Insider Buy |
Kurt M. Eichler Director |
$12.00
CAGR »
|
$499,992.00 41,666 shares |
5-11-2016 Insider Buy |
Martin J. Driscoll President and CEO |
$12.00
CAGR »
|
$150,000.00 12,500 shares |
Also See: Institutional Holders of SBPH
Also See: SEC filings
Below we present the annualized performance delivered by SBPH stock since 11-14-2019 (the date of the most recent
insider purchase). The performance of the investment from the time SBPH insider buying occurred is the ultimate
test of whether insiders were right about SBPH being a good buy.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
11/15/2019 |
|
| End date: |
11/20/2020 |
|
| Start price/share: |
$3.20 |
|
| End price/share: |
$1.21 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-62.19% |
|
| Average Annual Total Return: |
-61.59% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$3,781.06 |
|
| Years: |
1.02 |
|
SBPH Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.),
and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these
categories, but instead file their holdings quarterly on the latest form 13F filings.
While recent SBPH insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding SBPH
|
 |